Combined modality treatment with selective bladder conservation for invasive bladder cancer: Long-term tolerance in the female patient

Cancer Journal from Scientific American

Volumn 2, Issue 2, 1996, Pages 79-84

  Kachnic, Lisa A ^a   Shipley, William U ^a   Griffin, Pamela P ^a   Zietman, Anthony L ^a   Kaufman, Donald S ^a   Althausen, Alex F ^a   Heney, Niall M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bladder cancer; Bladder preservation; Chemotherapy; Radiotherapy; Transurethral surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RADIOTHERAPY; SURVIVAL; TIME; TRANSITIONAL CELL CARCINOMA; UROLOGIC SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RADIOTHERAPY; SURVIVAL ANALYSIS; TIME FACTORS; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 0002582506     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Efird JT. Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 1993;329:1377.
2. Tester W, Porter A, Asbell S et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Intl J Radiat Oncol Biol Phys 1993;25:783.
3. Housset M, Maulard C, Chretien YC et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993;11:2150.
4. Dunst J, Sauer R, Schrott KM. Organ-sparing treament of advanced bladder cancer: a 10 year experience. Ind J Radiat Oncol Biol Phys 1994;30:261.
5. Sell A, Jakobsen A, Nerstrom B. Treatment of advanced bladder cancer category T2, T3, T4a. Scand J Urol Nephrol Suppl 1991;138:193.
6. Fair WR, Fuks ZY, Scher HI. Cancer of the bladder. In: DeVita VT, Hellman SH, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: J.B. Lippincott, 1993:1052.
7. Zietman AL, Shipley WU, Kaufman DS. The combination of cisplatin based chemotherapy and radiation in the treatment of muscle-invasive transitional cell carcinoma of the bladder. Intl J Radiat Oncol Biol Phys 1993;27:161.
8. Yates JW, Edwards B. Practical concerns and pitfalls in measurement methodology. Cancer 1984;53[suppl]:2376.
9. Ganz PA, Haskell CM, Figlin RA, LaSoto N and Siaus J. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky Performance Status and the Functional Living Index-Cancer. Cancer 1988;61:849.
10. Schipper H, Levitt M. Measuring quality of life: risks and benefits. Cancet Treat Rep 1985;69:1115.
11. van Dam FSAM, Aaronson NK. Practical problems in conducting cancer-related psychosocial research. In: Aaronson NK, Beckmann JH, eds. The Quality of Life of Cancer Patients. New York: Raven Press, 1987.
12. Anderson JP, Bush JW, Berry CC. Classifying function for health outcome and quality-of-life evaluation: self-versus interviewer modes. Med Care 1986;24:454.
13. Hunt SM, McEwan J, McKenna SP. Measuring Health Status. Dover, NH: Croom Helm, 1986.
14. Madsen PO, Iversen P. A point system for selecting patients for operative candidates. In: Hinman Jr., ed. Benign Prostatic Hypertrophy. New York: Springer-Verlag, 1993:763.
15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Amer Stat Assoc 1958;53:457.
16. Cox DR and Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984.
17. Raghavan D, Grundy R, Lancaster L. Assessment of quality of life in long-term survivors treated by first-line intravenous cisplatin for invasive bladder cancer. In: Smith PH, Pavone-Macaluso M, eds. Management of Advanced Cancer of Prostate and Bladder. New York: Liss, 1988:625.
18. Lynch WJ, Jenkins BJ, Fowler CG, Hope-Stone HF, Blandy JP. The quality of life after radical radiotherapy for bladder cancer. Brit J Urol 1992;70:519.
19. Mommsen S, Jakobsen A, Sell A. Quality of life in patients with advanced bladder cancer. A randomized study comparing cystectomy and irradiation - the Danish Bladder Cancer Study Group (DAVECA protocol 82010). Scand J Urol Nephrol 1989[suppl]:125.
20. Fossa SD, Aaronson N, Calais da Silva F, Denis L, Newling D, Hosbach G, Kaalhus O. Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer. Eur Urol 1989;16:335.